Biopharmaceutical, Energy, Oncology, Data Centers

Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for ophthalmic and dermatologic diseases. Its lead product, XDEMVY, targets Demodex blepharitis, providing an innovative solution for eye health. Chart

Flotek Industries, Inc. (FTK)

Flotek Industries, Inc. provides advanced chemistry-based solutions for the energy sector. The company specializes in sustainable fluid systems that enhance oil and gas production while reducing environmental impact. Chart

Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology, Inc. is a clinical-stage biotechnology company developing novel cancer treatments. Its lead drug candidate, onvansertib, aims to enhance the effectiveness of standard cancer therapies by targeting tumor resistance mechanisms. Chart

TSS, Inc. (TSSI)

TSS, Inc. provides infrastructure and technology services for mission-critical data centers. The company offers design, maintenance, and security solutions, helping enterprises optimize IT performance and reliability. Chart

 
Trending Ideas
Featured Stocks On The Move
Daily Rundown
Top 3 Stocks in Leading Sectors

  • 3 Natural Gas Utility Stocks To Buy Now

    Spire Inc. (SR) Spire Inc. is a natural gas utility company serving residential, commercial, and industrial customers. The company focuses on infrastructure modernization, energy efficiency, and expanding renewable natural gas... Read More

  • 3 Biopharmaceutical Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a pharmaceutical company specializing in innovative drug formulations. The company develops ready-to-use injectable treatments for conditions like diabetes and rare... Read More

  • 3 E-Commerce Stocks To Buy Now

    Sea Limited (SE) Sea Limited is a digital services company with operations in e-commerce, gaming, and digital financial services. The company owns Shopee, Garena, and SeaMoney, offering internet-based consumer and... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    Cumberland Pharmaceuticals Inc. (CPIX) Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing hospital acute care and gastroenterology drugs. The company provides innovative treatments for underserved... Read More

  • 3 Semiconductor Stocks To Buy Now

    Allegro MicroSystems, Inc. (ALGM) Allegro MicroSystems, Inc. is a semiconductor company specializing in power and sensing solutions. The company develops high-performance integrated circuits for automotive, industrial, and consumer applications, enhancing... Read More

  • 3 Pharma Stocks To Buy Now

    Arcutis Biotherapeutics, Inc. (ARQT) Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on developing innovative dermatology treatments. The company specializes in topical therapies for inflammatory skin conditions such as psoriasis... Read More

  • 3 Finance Stocks To Buy Now

    Hanover Insurance Group Inc. (THG) Hanover Insurance Group Inc. is a property and casualty insurance company providing coverage for businesses, individuals, and specialty markets. The company offers a range of... Read More

  • 3 Tech Service Stocks To Buy Now

    Sezzle Inc. (SEZL) Sezzle Inc. is a financial technology company that provides buy now, pay later (BNPL) solutions. The platform allows consumers to split purchases into interest-free installments, supporting merchants... Read More

© Copyright 2020 Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.